Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Geissinger

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Oncogene|May 9, 2017
The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformationK Maurus, A Hufnagel, F Geiger, et al.
British Journal of Cancer|September 5, 2013
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practiceS Gahr, R Stoehr, E Geissinger, et al.
Leukemia|November 20, 2015
Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signalingM Kordes, M Röring, C Heining, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2020
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic featuresW Kempf, C Mitteldorf, M Battistella, et al.
The British Journal of Dermatology|September 30, 2018
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patientsJ J Scarisbrick, P Quaglino, H M Prince, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Oncogene|May 9, 2017
The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformationK Maurus, A Hufnagel, F Geiger, et al.
British Journal of Cancer|September 5, 2013
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practiceS Gahr, R Stoehr, E Geissinger, et al.
Leukemia|November 20, 2015
Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signalingM Kordes, M Röring, C Heining, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2020
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic featuresW Kempf, C Mitteldorf, M Battistella, et al.
The British Journal of Dermatology|September 30, 2018
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patientsJ J Scarisbrick, P Quaglino, H M Prince, et al.
Pageof 3